MetrioPharm is a clinical stage pharmaceutical development company.
MetrioPharm has raised $121K in total funding. The most recent round was Grant. The last funding was announced in October 2022.
MetrioPharm's investors include Duchenne UK.
MetrioPharm is headquartered in Zürich, Switzerland.
MetrioPharm is a clinical stage pharmaceutical development company.
MetrioPharm is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"MetrioPharm — Funding & Investors." VCBacked, October 12, 2022, https://www.vcbacked.co/company/metriopharm. Accessed October 14, 2026.
VCBacked. (2022). MetrioPharm — Funding & Investors. Retrieved October 14, 2026, from https://www.vcbacked.co/company/metriopharm
{{cite web |title=MetrioPharm — Funding & Investors |url=https://www.vcbacked.co/company/metriopharm |website=VCBacked |access-date=October 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated